Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-05-05 @ 9:34 AM
Study NCT ID:
NCT04889768
Status:
UNKNOWN
Last Update Posted:
2021-05-17
First Post:
2021-05-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis
Sponsor:
Zhejiang Cancer Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery | View |
Keywords: